The thought leaders in our community are good about sharing their thoughts on the issues of today. Here are the top read and shared guest posts of September that we think deserve sharing again.
By Devin Partida – Running a medical practice can be an expensive business. Most practices in the U.S. today have overheads worth between 60% and 70% of their revenue. That’s a troubling figure in any context, but considering the economic disruptions of the past two years, reducing costs may be particularly pressing now.
By Devin Partida – There’s been a recent boom in telehealth services that some people say could forever change care delivery. Teleneurology is a related trend. Here’s a look at what it is and how the option could help patients.
By Devin Partida – The past year has been a turning point for many industries, especially health care. The medical sector embraced new technologies and services at a record pace in the face of the COVID-19 pandemic. Perhaps the most recognizable and impactful of these changes was telehealth and virtual care.
By Devin Partida – How we dealt with the COVID-19 pandemic changed the world irrevocably. The rapid acceleration to remote operations, and all the changes that came with it, uprooted many industries, including health care.
By Devin Partida – Magnetic resonance imaging (MRI) scans can detect early signs of breast cancer, leading to more timely treatment. However, a false-positive result based on MRI scans can cause unnecessary tests and treatments like biopsies and potentially surgery.
By Devin Partida – As the COVID-19 pandemic disrupted the world, people who had never had to wear personal protective equipment (PPE) at work before began engaging in new activities that health care providers know well — wearing items that help keep them safe from pathogens.
It is day three of our 12 Days of Christmas Posts and we say Merci, to these three not French but frequent and dependable contributors to our Health IT Answers news site. Thank you Matt, Bill, and Devin.
By Devin Partida – When the news broke that early data showed the BioNTech-Pfizer vaccine against COVID-19 far surpassed expectations, the world rejoiced.